OBodies Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Undetermined
  • Financing Rounds
  • 3

OBodies General Information

Description

Operator of a pharmaceutical platform. The company offers cost effective production systems compared to monoclonal antibodies, unique patent position and freedom to operate to the pharmaceutical sector.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
  • C/o Private Bag 3105
  • Hamilton, 3240
  • New Zealand
+64 07-838 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OBodies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OBodies‘s full profile, request access.

Request a free trial

OBodies Executive Team (2)

Name Title Board Seat Contact Info
Grant Waring Executive, Finance
To view OBodies’s complete executive team members history, request access »

OBodies Board Members (2)

Name Representing Role Since
000000 0000000 Self Director 000 0000
To view OBodies’s complete board members history, request access »

OBodies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OBodies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OBodies‘s full profile, request access.

Request a free trial